Tickborne 2.0 Panel (Vibrant Wellness): Lyme + Co-Infections + PCR DNA

(Why this test can be a smart “clarity step” for brain fog, chronic fatigue, and mystery inflammation.)

If you’ve lived with brain fog, crushing fatigue, joint pain, “random” flares, or symptoms that don’t fit neatly into one box… you already know how exhausting the guessing game can be.

Sometimes the story is simple: sleep debt, nutrient depletion, gut imbalance, hormone shifts, or chronic stress physiology.

But sometimes the story is layered. And for many people—especially those who spend time outdoors, live in tick-dense regions, have pets, garden, hike, hunt, camp, or simply exist in the real world—tick-borne illness is one of the layers worth exploring.

Here’s the clinical reality: tick-borne disease evaluation can be tricky. Different organisms can cause overlapping symptoms, the body’s antibody response changes over time, and no single test is perfect. That’s why broad, pattern-based testing can be helpful as a starting map—especially when symptoms are persistent, relapsing, or unexplained.

That’s where the Tickborne 2.0 Panel by Vibrant Wellness comes in: it combines IgG/IgM antibody testing (immune response) with PCR DNA testing (direct detection) in one comprehensive panel designed to explore Lyme disease and a wide range of common co-infections and opportunistic infections.

Ticks can transmit more than one organism in a single bite. That matters because:

• Different organisms can trigger different symptom patterns

• Co-infections can complicate immune response and recovery

• Symptoms can be cyclical, migratory, or multi-system

• Early illness can look like a flu… and later illness can look like almost anything

The Centers for Disease Control and Prevention lists a wide range of tickborne diseases present in the U.S., including Lyme disease, anaplasmosis, babesiosis, ehrlichiosis, multiple rickettsial illnesses, and both hard- and soft-tick relapsing fever syndromes.

That doesn’t mean every person with fatigue has a tick-borne illness. It means: if your symptoms match the pattern and your history fits, it’s reasonable to look.

Symptom clusters that commonly overlap with tick-borne illness

These are not diagnostic, but they’re common reasons people go looking for answers:

• Brain fog / cognitive slowness / word-finding issues

• Chronic fatigue / post-exertional crashes

• Joint pain / muscle aches / migrating pain

• Headaches

• Dizziness / lightheadedness

• Sleep disruption

• Mood changes (anxiety, irritability, low mood)

• Neuropathy-like symptoms (tingling, burning, “electrical” sensations)

• Fevers/sweats/chills (especially cyclical)

• New or worsening exercise intolerance

In your symptom guide, brain fog and fatigue are already positioned as “big umbrella” symptoms that often require deeper investigation beyond routine labs. That’s exactly the mindset this blog supports.

Standard Lyme testing can miss cases (timing matters)

Many conventional Lyme evaluations rely on two-tier serologic testing (two-step antibody testing). This approach can be very helpful—especially later in illness—but it has known limitations in early infection.

A key issue is the “window period”: early infection may have low antibody sensitivity while the immune response is still developing. A CDC-associated review in Emerging Infectious Diseases notes that the sensitivity of two-tier testing is low (often cited around 30–40%) in early infection, while sensitivity improves in disseminated disease.

The CDC also provides detailed guidance on when Lyme serologic testing is indicated and how results should be interpreted (including standard and modified two-tier approaches).

And major clinical guidelines from Infectious Diseases Society of America, the American Academy of Neurology, and the American College of Rheumatology emphasize evidence-based testing and careful interpretation in context of symptoms and exposure risk.

Translation

• Antibody tests can be too early to show a clear signal

• Some symptoms show up before the immune system “makes the paperwork”

• If you only test for Lyme and ignore co-infections, you may miss part of the picture

This is why many clinicians appreciate combined strategies that look at both immune response and direct detection—especially when symptoms persist or are complicated.

---

What is the Tickborne 2.0 Panel?

The Tickborne 2.0 Panel is a comprehensive test designed to evaluate:

1. IgG and IgM antibodies to tickborne organisms (your immune response)

2. PCR DNA for tickborne organisms (direct detection)

According to Vibrant Wellness, the panel uses a combination of microarray/immunoassay technology plus PCR to evaluate Lyme disease, tickborne relapsing fever, and a broad range of co-infections.

Their support documentation also clarifies that Tickborne 2.0 includes four sub-panels, expanding beyond earlier versions by adding additional co-infections and an opportunistic infections section.

Why “IgG + IgM + PCR DNA” matters

• IgM often reflects a more recent immune response (not always, but often)

• IgG often reflects longer-term immune memory (past exposure or ongoing immune stimulation)

• PCR DNA can support direct detection (but can still be negative if organism levels are low or not circulating in the sample)

In other words: this is a multi-lens look, not a single snapshot.

---

What infections does it explore?

Different versions and marker lists can vary, but Vibrant Wellness describes coverage that includes:

• Lyme disease organisms (Borrelia group)

• Tickborne relapsing fever Borrelia species

• Co-infections such as Babesia, Bartonella, Ehrlichia, Rickettsia (and others)

• An “opportunistic infections” section (in the 2.0 expanded format)

And zooming out, the Centers for Disease Control and Prevention lists tickborne diseases that are clinically relevant in the U.S. landscape, reinforcing why a broader lens can matter when symptoms don’t match a single neat diagnosis.

Important note:
A broad panel is not the same as a diagnosis. It’s a way to gather pattern data that should be interpreted in the context of symptoms, exposure risk, and clinical evaluation.

---

Who is this test for?

This is a reasonable test to consider if you identify with one or more of these situations:

1) Persistent, unexplained symptoms that don’t resolve

Especially:

• brain fog + fatigue

• fatigue + joint pain

• flares that feel inflammatory or immune-driven

Your MyLabsForLife symptom guide highlights brain fog and chronic fatigue as key categories that often require deeper exploration beyond routine labs—and tickborne illness can be one of the contributors in the right context.

2) You have tick exposure risk (even if you never saw a tick)

You don’t need a classic story to have risk. Consider:

• hiking, camping, hunting, fishing

• gardening or working outdoors

• living in wooded/brush areas

• pets that go outdoors

• frequent travel to tick-endemic areas

3) You were “tested for Lyme” but still don’t have clarity

• only tested with a narrow approach

• no co-infections assessed

• symptoms continued despite negative or ambiguous results

Because early serology can miss cases during the window period, timing and test strategy matter.

4) Your symptom pattern suggests possible co-infections

Co-infections can influence symptom style and severity—and can be missed if the only question asked is “Lyme: yes or no?”

---

What makes Tickborne 2.0 different from basic testing?

Instead of evaluating only Lyme disease, this panel is designed to assess Lyme + relapsing fever Borrelia + co-infections in one structured report.

Multiple methods: antibodies + PCR DNA

• Antibodies (IgG/IgM) help assess immune response patterns

• PCR DNA helps assess direct detection of microbial genetic material (when present)

That combination can be useful when symptoms are persistent or complex.

A “map,” not a verdict

This matters for how you present it on your site:

This test is not a diagnosis.

It’s a data-rich tool to help a clinician make more informed decisions.

---

How to prepare for the test:

One reason people like this test is that it’s straightforward from a logistics standpoint.

Vibrant Wellness notes no fasting is required for their tickborne panel.

Before your blood draw

• Hydrate well the day before and the morning of (unless your clinician has restricted fluids)

• Eat normally unless instructed otherwise

• If you’re prone to fainting, request a draw while lying down

• Bring a snack and water for afterward

What to track before testing (helps support interpretation)

For 7–14 days, jot down:

• symptom intensity (0–10)

• timing (morning vs evening)

• flares after exertion or stress

• fevers/sweats/chills

• pain location changes

• sleep quality

This turns your results into a story instead of a random printout.

---

Interpreting results: what they can and cannot tell you

What the panel can help you explore

• Whether your immune system shows antibody patterns to specific organisms

• Whether PCR DNA detection is present for certain targets (if circulating/available in the sample)

• Whether multiple organisms show signals that might fit your symptom pattern

What it cannot do on its own

• It cannot definitively diagnose tick-borne disease withouta  clinical context

• It cannot tell you “when” you were exposed with perfect certainty

• It cannot guarantee that a negative result rules out tick-borne illness

This aligns with mainstream guidance: tick-borne disease testing must be interpreted carefully, and Lyme serology in particular has important timing and interpretation nuances.

---

Limitations

1) Timing affects antibodies

Early illness can test negative if the immune response hasn’t developed yet.

2) PCR can be “right” and still negative

PCR detects DNA when present in the sample. If organism levels are low or not circulating at the time of draw, PCR can be negative even in true illness.

3) Exposure ≠ active disease

Antibodies can reflect prior exposure. That’s why symptoms and clinical correlation matter.

4) Co-infections vary by region

Tick-borne disease ecology differs across the U.S. (and globally). The CDC’s tickborne disease resources are a useful anchor for understanding what’s common where you live.

---

How this fits into a “root cause roadmap”

A symptom guide helps you and your provider to frame big complaints like brain fog and chronic fatigue. Rarely is there only  “one thing.” There is often a convergence of:

• gut-immune signaling

• inflammation load

• metabolic stress

• sleep disruption

• nutrient depletion

• environmental exposures
  …and sometimes infection patterns

If the person’s main symptom is BRAIN FOG

Consider a “three-lens” approach:

1. Gut + inflammation lens (GI-MAP with Zonulin)

2. Energy + nutrient lens (Organic Acid Test – OAT)

3. Infection/immune lens (Tickborne 2.0 Panel)

If the person’s main symptom is CHRONIC FATIGUE

Start with:

1. Organic Acid Test (OAT)

2. Mold/mycotoxin lens

3. Hormone/stress lens

4. Infection/immune lens

This is not “more tests for the sake of tests.” This is sequencing—choosing the next best clarity step based on the dominant symptom pattern. And remember, journaling can be a HUGE support in sleuthing out patterns and potential health problems

---

FAQs

Does this test diagnose Lyme disease?

It provides data (antibody patterns + PCR DNA sig

It does not replace diagnosis by a licensed clinician. Mainstream clinical guidance emphasizes context, timing, and appropriate interpretation of Lyme testing. It helps support a pattern often seen in those who have Lyme Disease

Do I need to fast?

No fasting is required for their tickborne panel.

Why test for co-infections?

Because ticks can transmit multiple organisms, and co-infections can change symptom patterns and recovery trajectories. The CDC lists multiple tick-borne diseases that clinicians consider depending on the region and symptom presentation.

What symptoms make this test worth considering?

Common reasons include persistent brain fog, chronic fatigue, joint/muscle pain, headaches, neurologic symptoms, cyclical fevers/sweats, or relapsing inflammatory symptoms—especially with outdoor/tick exposure risk.

What if my results are “borderline” or confusing?

That’s common in real life. Borderline patterns should be reviewed with a skilled clinician who can interpret them in the context of timing, symptoms, history, physical exam, and other labs.

---

Ready for clarity?

If you’re dealing with persistent brain fog, chronic fatigue, joint pain, or relapsing symptoms—especially with a history of outdoor/tick exposure—the Tickborne 2.0 Panel can be a powerful next step to explore Lyme disease and co-infections using both antibody and PCR DNA testing.

Order through MyLabsForLife and bring your results to a licensed clinician for personalized interpretation.

Not sure where to start? Use our symptom-based guide to choose the best “first test” for your dominant concern.

REFERENCES

1. Vibrant Wellness. (n.d.). Tickborne Disease & Co-infection Testing (Tickborne Diseases Panel).
2. Vibrant (Help Center). (2023, August 14). What is the difference between Tickborne 1.0 and Tickborne 2.0?
3. Centers for Disease Control and Prevention. (2024, May 15). About ticks and tick-borne disease.
4. CDC. (2024, July 15). Tickborne disease surveillance data summary (U.S.).
5. CDC. (2025, March). Tickborne Diseases of the United States: A reference manual for healthcare providers (PDF).
6. CDC. (2024, May). Suggested reporting language, interpretation, and guidance regarding Lyme disease serologic test results (PDF).
7. CDC. (2024, May). Standard two-tier Lyme disease testing: Suggested results reporting & interpretation (PDF).
8. Infectious Diseases Society of America, American Academy of Neurology, & American College of Rheumatology. (2020, November 30). 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease (guideline page).
9. Lantos, P. M., et al. (2021). Clinical practice guidelines by the IDSA, AAN, and ACR: 2020 guidelines for the prevention, diagnosis, and treatment of Lyme disease. Clinical Infectious Diseases.
10. Branda, J. A., & Steere, A. C. (2021). Laboratory diagnosis of Lyme borreliosis. Clinical Microbiology Reviews

---

Important Medical Disclaimer

This article is for educational purposes only and is not medical advice. Lab testing is one tool for exploring contributing factors. Results should be interpreted by a licensed healthcare professional in the context of symptoms, history, and physical exam. Seek urgent medical care for severe, sudden, or worsening symptoms.